Cordia gilletii
Cordia gilletii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cordia gilletii is a botanical species that has garnered interest due to its unique chemical profile. Scientific investigations have focused on identifying key bioactive compounds within the plant, specifically ferulaldehyde and lupeol. Researchers primarily utilize the root and leaf as the essential plant parts for study. Through the use of methanol extract preparations, the medicinal potential of these components can be more effectively analyzed. This plant represents a significant subject for further pharmacological exploration.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Boraginaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Taxonomy
Cordia gilletii is a distinctive organism belonging to the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. This species is a member of the order Boraginales, showcasing its evolutionary connections. Furthermore, it falls under the family Boraginaceae, which helps define its botanical characteristics. Ultimately, its precise scientific identity is rooted in the genus Cordia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Boraginales |
| Family | Boraginaceae |
| Genus | Cordia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cordia gilletii is a distinctive plant species primarily found across the African continent. Its geographic presence is most concentrated within the lush environments of West-Central Tropical Africa. Specifically, the species thrives within the expansive landscapes of the DR Congo. This regional distribution highlights the plant's reliance on the unique tropical ecosystems found in these parts of Africa. Understanding its specific habitat is essential for studying the biodiversity of the Congo Basin.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cordia gilletii is characterized by its distinct growth form as a tree.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Cordia gilletii is a medicinal plant from the Boraginaceae family that has been traditionally used to combat infectious diseases. Recent investigations into its root barks have identified key bioactive compounds, specifically ferulaldehyde and lupeol. The isolation of ferulaldehyde from methanol extracts reveals its significant antimicrobial and antioxidant properties. Meanwhile, the presence of lupeol in n-hexane extracts provides indirect antimicrobial benefits by enhancing the efficacy of certain antibiotics. Together, these compounds help explain the plant's therapeutic potential against various pathogenic bacteria.
Conditions
Cordia gilletii acts as an effective agent in treating infectious diseases caused by P. aeruginosa. The plant's extracts work by quenching the quorum sensing mechanisms of Pseudomonas aeruginosa PAO1. This disruption specifically treats the production of pyocyanine, a major virulence factor. Additionally, Cordia gilletii treats biofilm formation by PAO1 through the inhibition of regulated genes. These combined actions support the plant's traditional use in managing bacterial infections.
Preparations
Cordia gilletii is prepared as a methanol extract to investigate its medicinal properties. This specific extract demonstrates significant activity against various pathogenic bacteria, including resistant strains. Through bio-guided fractionation of the methanol extract, researchers successfully isolated the compound ferulaldehyde. This isolated compound exhibits both antimicrobial and antioxidant properties that contribute to the overall efficacy of the plant extract. These findings help validate the traditional medicinal uses of the species against infectious diseases.
Parts used
Cordia gilletii is a medicinal plant from the Democratic Republic of Congo that demonstrates significant therapeutic potential against infectious diseases. Research indicates that different parts of the plant, specifically the leaves and the roots, contain bioactive compounds capable of fighting pathogens. Extracts derived from the leaves have been investigated for their ability to disrupt the communication mechanisms of bacteria like Pseudomonas aeruginosa. Furthermore, the root bark serves as a rich source of antimicrobial agents, such as ferulaldehyde and lupeol, which can inhibit virulence or enhance the efficacy of existing antibiotics. By utilizing both the leaves and roots, scientists hope to better understand how this plant supports traditional medical practices.